logo
logo

Oxford Cancer Analytics Grabs £1.27M To Revolutonise Lung Cancer Management

Sep 06, 2021almost 4 years ago

Amount Raised

£1.27 Million

Round Type

seed

Description

In the UK, it is reported that nearly 130 people are diagnosed with lung cancer every day. An early diagnosis will give a 57 per cent chance of survival for more than five years as compared to diagnosing at a later stage, wherein the survival rate is a meagre 3 per cent. This is where Oxcan (Oxford Cancer Analytics) comes to play as it strives to identify more cases in the early stage.

Company Information

Company

Oxford Cancer Analytics